Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer

被引:37
作者
Hovdenak, N
Wang, JR
Sung, CC
Kelly, T
Fajardo, LF
Hauer-Jensen, M
机构
[1] Bergen Univ Hosp, Dept Oncol, Bergen, Norway
[2] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
[4] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA
[5] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA
[6] Vet Healthcare Syst, Palo Alto, CA USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2002年 / 53卷 / 04期
关键词
prostate cancer; radiation therapy; matrix metalloproteinases; rectum; inflammation;
D O I
10.1016/S0360-3016(02)02808-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Rectal toxicity (proctitis) is a dose-limiting factor in pelvic radiation therapy. Mucosal atrophy, i.e., net extracellular matrix degradation, is a prominent feature of radiation proctitis, but the underlying mechanisms are not known. We prospectively examined changes in matrix metalloproteinase (MMP)-2 and MMP-9 (gelatinase A and B) in the rectal mucosa during radiation therapy of prostate cancer, as well as the relationships of these changes with symptomatic, structural, and cellular evidence of radiation proctitis. Methods and Materials: Seventeen patients scheduled for external beam radiation therapy for prostate cancer were prospectively enrolled. Symptoms of gastrointestinal toxicity were recorded, and endoscopy with biopsy of the rectal mucosa was performed before radiation therapy, as well as 2 and 6 weeks into the treatment course. Radiation proctitis was assessed by endoscopic scoring, quantitative histology, and quantitative immunohistochemistry. MMP-2 and MMP-9 were localized immunohistochemically, and activities were determined by gelatin zymography. Results: Symptoms, endoscopic scores, histologic injury, and mucosal macrophages and neutrophils increased From-baseline to 2 weeks. Symptoms increased further from 2 weeks to 6 weeks, whereas endoscopic and cellular evidence of proctitis did not. Compared to pretreatment values, there was increased total gelatinolytic activity of MMP-2 and MMP-9 at 2 weeks (p = 0.02 and p = 0.004, respectively) and 6 weeks (P = 0.006 and p = 0.001, respectively). Active MMP-2 was increased at both time points (p = 0.0001 and p = 0.002). Increased MMP-9 and MMP-2 at 6 weeks was associated with radiation-induced diarrhea (p = 0.007 and p = 0.02, respectively) and with mucosal neutrophil infiltration (rho = 0.62). Conclusions: Pelvic radiation therapy causes increased MMP-2 and MMP-9 activity in the rectal mucosa. These changes correlate with radiation-induced diarrhea and granulocyte infiltration and may contribute to abnormal connective tissue remodeling in radiation proctitis. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:919 / 927
页数:9
相关论文
共 45 条
[1]   DISTRIBUTION OF THE MATRIX METALLOPROTEINASES STROMELYSIN, GELATINASE-A AND GELATINASE-B, AND COLLAGENASE IN CROHNS-DISEASE AND NORMAL INTESTINE [J].
BAILEY, CJ ;
HEMBRY, RM ;
ALEXANDER, A ;
IRVING, MH ;
GRANT, ME ;
SHUTTLEWORTH, CA .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (02) :113-116
[2]  
Belkhiri A, 1997, LAB INVEST, V77, P533
[3]  
Brooks P. C., 2001, International Journal of Radiation Oncology Biology Physics, V51, P156, DOI 10.1016/S0360-3016(01)02106-X
[4]   TRANSFORMING GROWTH-FACTOR-BETA - A PROMOTOR OF LATE CONNECTIVE-TISSUE INJURY FOLLOWING RADIOTHERAPY [J].
CANNEY, PA ;
DEAN, S .
BRITISH JOURNAL OF RADIOLOGY, 1990, 63 (752) :620-623
[5]   Changing views of the role of matrix metalloproteinases in metastasis [J].
Chambers, AF ;
Matrisian, LM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (17) :1260-1270
[6]   Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease [J].
Daum, S ;
Bauer, U ;
Foss, HD ;
Schuppan, D ;
Stein, H ;
Riecken, EO ;
Ullrich, R .
GUT, 1999, 44 (01) :17-25
[7]   Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis [J].
Di Sebastiano, P ;
di Mola, FF ;
Artese, L ;
Rossi, C ;
Mascetta, G ;
Pernthaler, H ;
Innocenti, P .
DIGESTION, 2001, 63 (04) :234-239
[8]  
DURKO M, 1996, CELL ADHESION INVASI, P113
[9]   Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase [J].
Fang, KC ;
Raymond, WW ;
Lazarus, SC ;
Caughey, GH .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1589-1596
[10]  
Fang KC, 1999, J IMMUNOL, V162, P5528